Advertisement

Journal of Inherited Metabolic Disease

, Volume 30, Issue 2, pp 139–144 | Cite as

Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)

  • T. Ohura
  • K. Kobayashi
  • Y. Tazawa
  • D. Abukawa
  • O. Sakamoto
  • S. Tsuchiya
  • T. Saheki
ICIEM 2006

Summary

We clarified the clinical features of NICCD (neonatal intrahepatic cholestasis caused by citrin deficiency) by retrospective review of symptoms, management and long-term outcome of 75 patients. The data were generated from questionnaires to paediatricians in charge of the patients. Thirty of the patients were referred to hospitals before 1 month of age because of positive results in newborn screening (hypergalactosaemia, hypermethioninaemia, and hyperphenylalaninaemia). The other 45, the screen-negative patients, were referred to hospitals with suspected neonatal hepatitis or biliary atresia because of jaundice or discoloured stool. Most of the screen-negative patients presented before 4 months of age, and 11 had failure to thrive. Laboratory data showed elevated serum bile acid concentrations, hypoproteinaemia, low levels of vitamin K-dependent coagulation factors and hypergalactosaemia. Hypoglycaemia was detected in 18 patients. Serum amino acid analyses showed significant elevation of citrulline and methionine concentrations. Most of the patients were given a lactose-free and/or medium-chain triglyceride-enriched formula and fat-soluble vitamins. Symptoms resolved in all but two of the patients by 12 months of age. The two patients with unresolved symptoms suffered from progressive liver failure and underwent liver transplantation before their first birthday. Another patient developed citrullinaemia type II (CTLN2) at age 16 years. It is important to recognize that NICCD is not always a benign condition.

Keywords

Citrulline Biliary Atresia Newborn Screening Maple Syrup Urine Disease SLC25A13 Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

CTLN2

citrullinaemia type 2

NICCD

neonatal intrahepatic cholestasis caused by citrin deficiency

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Balistreri WF (1985) Neonatal cholestasis. J Pediatr 106: 171–186.PubMedCrossRefGoogle Scholar
  2. Ben-Shalom E, Kobayashi K, Shaag A, et al (2002) Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. Mol Genet Metab 77: 202–208.PubMedCrossRefGoogle Scholar
  3. Hachisu M, Oda Y, Goto M, et al (2005) Citrin deficiency presenting with ketotic hypoglycaemia and hepatomegaly in childhood. Eur J Pediatr 164: 109–110.PubMedCrossRefGoogle Scholar
  4. Imamura Y, Kobayashi K, Shibatou T, et al (2003) Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26: 68–72.PubMedCrossRefGoogle Scholar
  5. Kobayashi K, Shaheen N, Kumashiro R, et al (1993) A search for the primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet 53: 1024–1030.PubMedGoogle Scholar
  6. Kobayashi K, Horiuchi M, Saheki T (1997) Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25: 1160–1165.PubMedCrossRefGoogle Scholar
  7. Kobayashi K, Sinasac DS, Iijima M, et al (1999) The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 22: 159–163.PubMedCrossRefGoogle Scholar
  8. Kobayashi K, Lu YB, Li MX, et al (2003) Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol Genet Metab 80: 356–359.PubMedCrossRefGoogle Scholar
  9. Lee J, Ellaway C, Kobayashi K, Wilcken B (2002) Citrullinaemia type II: a rare cause of neonatal hepatitis detected by newborn screening. J Inherit Metab Dis 25 (Supplement 1): 29.CrossRefGoogle Scholar
  10. Lu YB, Kobayashi K, Ushikai M, et al (2005) Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 50: 338–346.PubMedCrossRefGoogle Scholar
  11. Naito E, Ito I, Matsuura S, et al (2002) Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening. J Inherit Metab Dis 25: 71–76.PubMedCrossRefGoogle Scholar
  12. Ohura T, Kobayashi K, Tazawa Y, et al (2001) Neonatal presentation of adult-onset type II citrullinemia. Hum Genet 108: 87–90.PubMedCrossRefGoogle Scholar
  13. Ohura T, Kobayashi K, Abukawa D, et al (2003) A novel inborn error of metabolism detected by elevated methionine and/or galactose in newborn screening: neonatal intrahepatic cholestasis caused by citrin deficiency. Eur J Pediatr 162: 317–322.PubMedGoogle Scholar
  14. Palmieri L, Pardo B, Lasorsa FM, et al (2001) Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060–5069.PubMedCrossRefGoogle Scholar
  15. Saheki T, Kobayashi K (2002) Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47: 333–341.PubMedCrossRefGoogle Scholar
  16. Saheki T, Kobayashi K, Inoue I, et al (1987), Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol 108: 21–68.PubMedCrossRefGoogle Scholar
  17. Shigematsu Y, Hirano S, Hata I, et al (2002) Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B 776: 39–48.CrossRefGoogle Scholar
  18. Tamamori A, Okano Y, Ozaki H (2002) Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur J Pediatr 161: 609–613.PubMedCrossRefGoogle Scholar
  19. Tamamori A, Fujimoto A, Okano Y, et al (2004) Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency. Pediatr Res 56: 608–614.PubMedCrossRefGoogle Scholar
  20. Tanaka T, Nagao M, Tsutsumi H, et al (2002) Application of mutation analysis for the previously uncertain cases of adult-onset type II citrullinemia (CTLN2) and their clinical profiles. Tohoku J Exp Med 198: 89–97.PubMedCrossRefGoogle Scholar
  21. Tazawa T, Kobayashi K, Ohura T, et al (2001) Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. J Pediatr 138: 735–740.PubMedCrossRefGoogle Scholar
  22. Tazawa Y, Kobayashi K, Abukawa D, et al (2004) Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients. Mol Genet Metab 83, 213–219.PubMedCrossRefGoogle Scholar
  23. Tomomasa T, Kobayashi K, Kaneko H, et al (2001) Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy. J Pediatr 138: 741–743.PubMedCrossRefGoogle Scholar
  24. Yamaguchi N, Kobayashi K, Yasuda T, et al (2002) Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum Mutat 19: 122–130.PubMedCrossRefGoogle Scholar
  25. Yasuda T, Yamaguchi N, Kobayashi K, et al (2000) Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 107, 537–45.PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer 2007

Authors and Affiliations

  • T. Ohura
    • 1
  • K. Kobayashi
    • 2
  • Y. Tazawa
    • 1
  • D. Abukawa
    • 1
  • O. Sakamoto
    • 1
  • S. Tsuchiya
    • 1
  • T. Saheki
    • 2
  1. 1.Depatment of PaediatricsTohoku University School of MedicineSendaiJapan
  2. 2.Department of Molecular Metabolism and Biochemical GeneticsKagoshima University Graduate School of Medicine and Dental SciencesKagoshimaJapan

Personalised recommendations